Bhavika Kaul is a Respiratory physician affiliated with Michael E. DeBakey VA Medical Center. OpenAlex indexes 43 publications with 1,211 citations (h-index 15); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1 Baylor Plz
Houston, TX 770303411
Telephone
713-798-4951Provider last certified this registry record 1 Dec 2021.
Clinical trials
- Metformin to Attenuate Progressive Respiratory Decline in Idiopathic Pulmonary Fibrosis
Sponsor: University of Massachusetts, Worcester
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Boehringer Ingelheim Pharmaceuticals, Inc.Program year20241 payment
- Boehringer Ingelheim Pharmaceuticals, Inc.Program year20232 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
NIH funding
1 NIH research award on record, funded 2025–2025 per NIH RePORTER. The latest:
- Improving Timely Access to Care for Veterans with Pulmonary Fibrosis Detected on Lung Cancer Screening
Michael E Debakey Va Medical Center
FY2025IK2HX003866
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- A statistical model for lung function trajectory and mortality in patients with fibrotic interstitial lung disease
American Journal of Respiratory and Critical Care Medicine
2026 - Drug Repurposing for Lung Disease: Mechanistic Rationale, Clinical Evidence, and the Path Forward
American Journal of Respiratory and Critical Care Medicine
2026 - Approach to the Evaluation and Management of Interstitial Lung Abnormalities: An Official American Thoracic Society Clinical Statement
American Journal of Respiratory and Critical Care Medicine
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Alan Swann, MD
Michael E. DeBakey VA Medical Center
Richard Hamill, MD
Michael E. DeBakey VA Medical Center
Vijay Nambi, MD
Michael E. DeBakey VA Medical Center
Ricardo Jorge, MD
Michael E. DeBakey VA Medical Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”